Juvaris BioTherapeutics has appointed Grant Pickering as CEO, replacing Martin Cleary, who founded the company in February, 2003.
Subscribe to our email newsletter
Mr Pickering will also be elected to the company’s board of directors. In conjunction with Mr Pickering’s appointment, the corporate headquarters will now be located within the company’s recently expanded research, development and manufacturing facilities in Burlingame, California.
Prior to joining Juvaris, Mr Pickering founded Pharmada, where he served as its president and CEO.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.